FDA approves Briviact to treat partial onset seizures - FDA Press Releases

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

from Food and Drug Administration--Press Releases http://ift.tt/21dvgKE
via IFTTT